FDA Approves Fayuvi Gene Therapy for Rare Sanfilippo SyndromeNovember 1, 2026 Health 3 Views The FDA has approved Fayuvi, a gene therapy for Sanfilippo syndrome, a rare inherited disease. The treatment costs nearly $4 million per patient.